Kulkarni Samarth bought CRSP
March 20, 2026 · Form 4 insider transaction
Kulkarni Samarth bought 81,875 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
81,875
Price
$0.00
Total value
N/A
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 20, 2026
Filing dateMarch 24, 2026
Shares owned after81,875
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030.; These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031.